Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Salles, G."'
Autor:
Epstein-Peterson ZD; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Drill E; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY., Aypar U; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY., Batlevi CL; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Caron P; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Dogan A; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY., Drullinsky P; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Gerecitano J; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Hamlin PA; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Ho C; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY., Jacob A; Adaptive Biotechnologies, Seattle, WA., Joseph A; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Laraque L; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Matasar MJ; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Moskowitz AJ; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Moskowitz CH; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Mullins C; Adaptive Biotechnologies, Seattle, WA., Owens C; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Salles G; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Schöder H; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Straus DJ; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Younes A; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Zelenetz AD; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Kumar A; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. kumara@mskcc.org.
Publikováno v:
Haematologica [Haematologica] 2024 Aug 01; Vol. 109 (8), pp. 2749-2752. Date of Electronic Publication: 2024 Aug 01.
Autor:
Morschhauser F; University of Lille, CHU Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France. franck.morschhauser@chru-lille.fr., Ghosh N; Hematologic Oncology and Blood Disorders, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA., Lossos IS; Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Palomba ML; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mehta A; Division of Hematology and Oncology, University of Alabama School of Medicine, Birmingham, AL, USA., Casasnovas O; Service d'Hématologie Clinique, CHU Dijon Bourgogne - Hôpital François Mitterrand, Dijon, France., Stevens D; Norton Cancer Institute, Norton Healthcare, Louisville, KY, USA., Katakam S; Product Development Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Knapp A; Product Development Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Nielsen T; Product Development Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland., McCord R; Genentech Inc., South San Francisco, CA, USA., Salles G; Haematology Department, Université Claude Bernard de Lyon, Lyon University Hospital, Pierre Benite, France.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2021 Aug 20; Vol. 11 (8), pp. 147. Date of Electronic Publication: 2021 Aug 20.
Autor:
Oberic L; Department of Hematology, Institut Universitaire du Cancer, Toulouse-Oncopole, Toulouse, France., Peyrade F; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France., Puyade M; Department of Oncology-Haematology and Cell Therapy, CHU, Poitiers, INSERM, Inserm CIC 1402, Poitiers, France., Bonnet C; Clinical Hematology Unit, CHU Liège, Liège Université, Campus Universitaire de Sart Tilman, Liège, Belgique., Dartigues-Cuillères P; Anapath Research Unit (EA) EA4340 and Pathology Laboratory, Versailles University and APHP, Ambroise Paré Hospital, Boulogne, France., Fabiani B; Department of Pathology, Hopital Saint-Antoine, APHP, Paris, France., Ruminy P; INSERM U1245, Centre Henri Becquerel, Rouen, France., Maisonneuve H; Department of Clinical Hematology, Centre Hospitalier Départemental Vendée, La Roche-sur-Yon, France., Abraham J; Department of Hematology, CHU Dupuytren, Limoges, France., Thieblemont C; APHP, Hopital Saint-Louis, Hemato-oncologie; Université de Paris, Paris Diderot, Paris, France., Feugier P; Department of Haematology, Centre Hospitalier Régional Universitaire de Nancy, Vandoeuvre Les Nancy, France., Salles G; Department of Hematology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France., Bijou F; Department of Hematology, Hospital Bergonié, Bordeaux, France., Pica GM; Department of Hematology, Centre Hospitalier Métropole Savoie, Chambery, France., Damaj G; Department of Hematology, CHU Caen, Caen, France., Haioun C; Department of Hematology, Henri Mondor University Hospital, UPEC, Creteil, France., Casasnovas RO; Department of Hematology and INSERM1231, CHU Dijon Bourgogne, Dijon, France., Farhat H; Department of Hematology, Centre Hospitalier de Versailles André Mignot, Versailles, France., Le Calloch R; Centre hospitalier de Quimper Cornouaille/Université de Bretagne Occidentale, France., Waultier-Rascalou A; Department of Hematology, Centre Hospitalier Universitaire Nimes Caremeau, Nîmes, France., Malak S; Department of Hematology, CLCC Rene Huguenin Institut Curie, Saint-Cloud, France., Paget J; LYSARC, The Lymphoma Academic Research Organisation, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France., Gat E; LYSARC, The Lymphoma Academic Research Organisation, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France., Tilly H; Department of Hematology, Centre Henri Becquerel, UNIROUEN, University of Normandy, INSERM U1245, Rouen, France., Jardin F; Department of Hematology, Centre Henri Becquerel, UNIROUEN, University of Normandy, INSERM U1245, Rouen, France.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Apr 10; Vol. 39 (11), pp. 1203-1213. Date of Electronic Publication: 2021 Jan 14.
Autor:
Vercellino L; Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Nuclear Medecine, Paris, France., Cottereau AS; Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Nuclear Medecine, René Descartes University, Paris, France., Casasnovas O; Service d'Hématologie Clinique, Centre Hospitalier Universitaire Dijon, INSERM UMR1231, Dijon, France., Tilly H; Department of Hematology, Centre Henri Becquerel, University Rouen, INSERM U1245, Rouen, France., Feugier P; Department of Hematology, Centre Hospitalier Universitaire Nancy, INSERM 1256, Nancy, France., Chartier L; The Lymphoma Academic Research Organisation, Statistic, Centre Hospitalier Lyon Sud, Pierre-Benite, France., Fruchart C; Hématologie, Institut d'Hématologie de Basse Normandie, Centre Hospitalier Universitaire, Caen, France., Roulin L; University Hospital Henri-Mondor Assistance Publique-Hôpitaux de Paris, Creteil, France., Oberic L; Hôpital de Purpan, Centre Hospitalier Universitaire Toulouse, Toulouse, France., Pica GM; Department of Hematology, Centre Hospitalier Métropole Savoie Chambéry, Chambéry, France., Ribrag V; Hematology, Institut Gustave Roussy, Villejuif, France., Abraham J; Centre Hospitalier Universitaire Dupuytren, Limoges, France., Simon M; Institut Jules Bordet, Brussels, Belgium., Gonzalez H; Centre Hospitalier René Dubos, Pontoise, France., Bouabdallah R; Department of Hematology, Institut Paoli Calmettes, Marseille, France., Fitoussi O; Hematology/Oncology, Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France., Sebban C; Hematologie, Centre Leon Berard, Lyon, France., López-Guillermo A; Hematology, Hospital Clinic Barcelona, Barcelona, Spain., Sanhes L; Hematology, Centre Hospitalier Marechal Joffre-Hôpital Saint-Jean, Perpignan, France., Morschhauser F; Hematology, Université Lille, Centre Hospitalier Universitaire Lille, EA 7365 Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France., Trotman J; Concord Repatriation General Hospital, University of Sydney, Concord NSW, Australia., Corront B; Service d'Hématologie Clinique, Centre Hospitalier Regional Annecy, Annecy, France., Choufi B; Hematology, Centre Hospitalier Dr Duchenne, Boulogne-Sur-Mer, France., Snauwaert S; Hematology, Algemeen Ziekenhuis Sint-Jan, Brugge, Belgium., Godmer P; Hematology, Centre Hospitalier Bretagne Atlantique, Vannes, France., Briere J; Pathology, INSERM U955, University Hospital Henri-Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France., Salles G; Department of Hematology, INSERM U1052 Hospices Civils de Lyon, University of Lyon, Pierre-Bénite, France., Gaulard P; Pathology, INSERM U955, University Hospital Henri-Mondor Assistance Publique-Hôpitaux de Paris, Créteil, France., Meignan M; Lymphoma Study Association-Imaging, Hospital Henri-Mondor, Assistance Publique-Hôpitaux de Paris, University Paris-Est Créteil, Créteil, France., Thieblemont C; Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Hemato-Oncology, Paris, France; and.; Sorbonne Paris Cité, Diderot University, Paris, France.
Publikováno v:
Blood [Blood] 2020 Apr 16; Vol. 135 (16), pp. 1396-1405.
Autor:
Morschhauser F; Service des Maladies du Sang, Centre Hospitalier Régional Universitaire de Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées, Université de Lille, Lille, France., Salles G; Hematology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, University of Lyon, Pierre-Benite, France., Le Gouill S; Department of Haematology, Centre Hospitalier Universitaire Nantes, Nantes, France., Tilly H; Département d'Hématologie, U1245, Centre Henri Becquerel, Université de Rouen, Rouen, France., Thieblemont C; Hemato-Oncology Department, Assistance Publique-Hôpitaux de Paris (AP-HP), INSERM U728, Hospital Saint-Louis, Institut Universitaire d'Hematologie, Paris, France., Bouabdallah K; Service d'Hématologie et de Thérapie Cellulaire, Centre Hospitalier Universitaire Bordeaux, Bordeaux, France., Fabiani B; Hopital Saint-Antoine, AP-HP, Paris, France., Ménard C; Unité Mixte de Recherche (UMR) S1236, INSERM, University of Rennes, Etablissement Français du Sang, Rennes, France.; Suivi Immunologique des Thérapeutiques Innovantes, Centre Hospitalier Universitaire de Rennes, Etablissement Français du Sang, Rennes, France., Tarte K; Unité Mixte de Recherche (UMR) S1236, INSERM, University of Rennes, Etablissement Français du Sang, Rennes, France.; Suivi Immunologique des Thérapeutiques Innovantes, Centre Hospitalier Universitaire de Rennes, Etablissement Français du Sang, Rennes, France., Cartron G; UMR 5235, Centre Hospitalier Universitaire, University of Montpellier, Montpellier, France; and., Houot R; Haematology Department, Centre Hospitalier Universitaire Rennes, Rennes, France.
Publikováno v:
Blood [Blood] 2018 Oct 04; Vol. 132 (14), pp. 1486-1494. Date of Electronic Publication: 2018 Aug 01.
Autor:
Besson L; CIRI, Centre International de Recherche en Infectiologie-International Center for Infectiology Research, Lyon, France.; INSERM, U1111, Lyon, France.; Ecole Normale Supérieure de Lyon, Lyon, France.; Université Lyon 1, Lyon, France.; CNRS, UMR5308, Lyon, France.; Laboratoire d'Immunologie, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite, France., Charrier E; CIRI, Centre International de Recherche en Infectiologie-International Center for Infectiology Research, Lyon, France.; INSERM, U1111, Lyon, France.; Ecole Normale Supérieure de Lyon, Lyon, France.; Université Lyon 1, Lyon, France.; CNRS, UMR5308, Lyon, France.; Laboratoire d'Immunologie, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite, France., Karlin L; Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d'Hematologie, Pierre-Benite, Universite Claude Bernard Lyon 1, Lyon, France., Allatif O; CIRI, Centre International de Recherche en Infectiologie-International Center for Infectiology Research, Lyon, France.; INSERM, U1111, Lyon, France.; Ecole Normale Supérieure de Lyon, Lyon, France.; Université Lyon 1, Lyon, France.; CNRS, UMR5308, Lyon, France., Marçais A; CIRI, Centre International de Recherche en Infectiologie-International Center for Infectiology Research, Lyon, France.; INSERM, U1111, Lyon, France.; Ecole Normale Supérieure de Lyon, Lyon, France.; Université Lyon 1, Lyon, France.; CNRS, UMR5308, Lyon, France., Rouzaire P; Service d'Immunologie, CHU de Clermont-Ferrand, équipe ERTICa EA4677, Université d'Auvergne, Clermont-Ferrand, France., Belmont L; Laboratoire d'Immunologie, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite, France., Attal M; Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Lombard C; Laboratoire d'Immunologie, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite, France., Salles G; Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d'Hematologie, Pierre-Benite, Universite Claude Bernard Lyon 1, Lyon, France., Walzer T; CIRI, Centre International de Recherche en Infectiologie-International Center for Infectiology Research, Lyon, France.; INSERM, U1111, Lyon, France.; Ecole Normale Supérieure de Lyon, Lyon, France.; Université Lyon 1, Lyon, France.; CNRS, UMR5308, Lyon, France., Viel S; CIRI, Centre International de Recherche en Infectiologie-International Center for Infectiology Research, Lyon, France.; INSERM, U1111, Lyon, France.; Ecole Normale Supérieure de Lyon, Lyon, France.; Université Lyon 1, Lyon, France.; CNRS, UMR5308, Lyon, France.; Laboratoire d'Immunologie, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.
Publikováno v:
Frontiers in immunology [Front Immunol] 2018 Apr 13; Vol. 9, pp. 704. Date of Electronic Publication: 2018 Apr 13 (Print Publication: 2018).
Autor:
Duell, J., Abrisqueta, P., Dreyling, M., Gaidano, G., Barca, E. G., Jurczak, W., Maddocks, K. J., Menne, T., Nagy, Z., Tournilhac, O., Bakuli, A., Amin, A., Gurbanov, K., Salles, G.
Publikováno v:
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p439-441, 3p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.